Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Zou, Yan  [Clear All Filters]
2013
Zou Y, Chiu H, Zinovyeva A, Ambros V, Chuang C-F, Chang C. Developmental decline in neuronal regeneration by the progressive change of two intrinsic timers. Science. 2013;340(6130):372-6.
2016
Dong X, Chiu H, Park YJenny, Zou W, Zou Y, Özkan E, Chang C, Shen K. Precise regulation of the guidance receptor DMA-1 by KPC-1/Furin instructs dendritic branching decisions. Elife. 2016;5.
2019
Xu J, Wang Y, He J, Xia W, Zou Y, Ruan W, Lou Q, Li Y, Li H, Chen W. Generation of a human Charcot-Marie-Tooth disease type 1B (CMT1B) iPSC line, ZJUCHi001-A, with a mutation of c.292C>T in MPZ. Stem Cell Res. 2019;35:101407.
Xu J, Fu Y, Xia W, He J, Zou Y, Ruan W, Lou Q, Li Y, Pan J, Li H, et al. Generation of induced pluripotent stem cell line, ZJUCHi002-A, from Charcot-Marie-Tooth disease type 2A (CMT2A) patient with a mutation of c.752C>T in MFN2. Stem Cell Res. 2019;36:101411.
2022
He W, Li X, Morsch M, Ismail M, Liu Y, Rehman FUr, Zhang D, Wang Y, Zheng M, Chung R, et al. Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy. ACS Nano. 2022.
2023
Zou Y, Sun Y, Wang Y, Zhang D, Yang H, Wang X, Zheng M, Shi B. Cancer cell-mitochondria hybrid membrane coated Gboxin loaded nanomedicines for glioblastoma treatment. Nat Commun. 2023;14(1):4557.
2024
He W, Wang N, Wang Y, Liu M, Qing Q, Su Q, Zou Y, Liu Y. Engineering Nanomedicine for Non-Viral RNA-Based Gene Therapy of Glioblastoma. Pharmaceutics. 2024;16(4).